Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma

NCT04552223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Uveal Melanoma

Interventions

DRUG: Nivolumab
DRUG: Relatlimab

Sponsor

Jose Lutzky, MD

Collaborators

[object Object]
[object Object]